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Abstract 
The publication of studies using next generation sequencing to analyse large numbers of bacterial isolates from global epidemics is 
transforming microbiology, epidemiology and public health. The emergence of multidrug resistant Salmonella Typhimurium ST313 is one 
example. While the epidemiology in Africa appears to be human-to-human spread and the association with invasive disease almost absolute, 
more needs to be done to exclude the possibility of animal reservoirs and to transfer the ability to track all Salmonella infections to the 
laboratories in the front line. In this mini-review we summarise what is currently known about non-typhoidal Salmonella in sub-Saharan 
Africa and discuss some of the issues which remain. 
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Introduction 
Background to the increase in non-typhoidal 
Salmonella 
In an unknown number of sub-Saharan African 
countries there is an increasing number of cases of 
multidrug resistant (MDR) non-typhoidal Salmonella 
(NTS) infection [1]. Previous authors highlight risk 
factors including human immunodeficiency virus 
(HIV) infection, extreme youth, malnutrition and 
malaria [2]. The greatest contributor to disease burden 
over the past decade is undoubtedly the increase in 
HIV-NTS co-infection [3,4,5,6] associated with a very 
high mortality [7,8]. The first report of NTS in an 
acquired immune deficiency syndrome (AIDS) patient 
was from Haiti in 1983 [9] and five case reports from 
New York, United States of America (USA,) all with 
S. Typhimurium, were reported in 1985 [10]. Since 
then the impact of HIV on the cause of invasive 
salmonellosis has been dramatic: In one hospital in Ho 
Chi Minh City, Viet Nam, positive blood cultures for 
S. Typhi dropped from hundreds per year in the 1990s  
 
to tens in the 2000s with an associated increase in NTS 
and Penicillium marneffei as the most common blood 
culture isolate [11]. Similarly, the increasing impact 
and differing epidemiology of NTS, compared with S. 
Typhi, is noted in several Africa countries [12] where 
NTS infection is expanding but the epidemiology has 
proved elusive. A systematic review of the literature 
suggests that NTS are responsible for nearly 60% of 
bloodstream infections due to Salmonella; NTS are 
now more common than enteric Salmonella [13].  In 
Zimbabwe, drug resistant invasive NTS infection was 
recognised as an increasing problem in the early 
nineties; between 1994 and 1996, 301 Salmonella 
were isolated from blood: 37.2% group D, 21.6% 
group B (possibly Salmonella Typhimurium) and 
12.0% group C [14]. Although the HIV status of the 
patients was not tested, it seems likely that this was the 
beginning of the HIV-associated increase in NTS in 
Africa.  
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Resistance to antibiotics and the emergence of 
sequence type 131 
Multidrug resistance in NTS has remained a 
challenge after the turn of this century, including 
resistance to extended spectrum beta-lactam agents 
[15] and emerging resistance to the quinolones [16]. 
The sub-types, or strains, of NTS associated with 
invasive salmonellosis were described in Kenya as 
“multiclonal” in the late nineties [17], and in Malawi 
as showing considerable “inter-individual 
heterogeneity” during the same time period [8]. Yet 
analyses of recent isolates, using the power of new 
sequencing technologies, has shown the emergence of 
a single group of S. Typhimurium sequence type 313 
(ST313). It seems from a soup of Salmonella serotypes 
and sub-types that one sub-type,  S. Typhimurium 
ST313, has swept through the human population in 
both Malawi [18] and Kenya [19]. 
The genome sequencing of a broad collection of 
African isolates now shows that S. Typhimurium 
ST313 is a clonal group of bacteria (sharing common 
ancestry) which has been circulating for around 50 
years and has now split into two lineages that have 
acquired similar resistance genes on separate 
occasions [20]. The microevolution of virulence gene 
expression has been associated with environmental 
stress [21] and it is possible that in sub-Saharan 
African countries extreme draught followed by rain 
storms, and hot days followed by cool nights, could 
have resulted it the emergence of a successful clone of 
S. Typhimurium. The genome data also show that 
several genes have been switched off by mutation or 
deletion of key genetic sequence thus creating 
“pseudogenes”. The presence of pseudogenes is the 
hallmark of genome degradation caused by niche 
specialisation, in this case most likely host adaptation. 
The process is well described in other human adapted 
enteric Salmonella such as S. Typhi and S. Paratyphi A 
and has occurred over an evolutionary time scale [22]. 
Therefore, either S. Typhimurium ST313 has been 
associated with humans for millennia, or more likely, 
it has emerged from a pathogen which was already 
adapted to an animal host, causing gastroenteritis in 
immune competent human hosts and invasive disease 
as a result of the immune deficiency of HIV infections. 
Unpublished data (RH and JW) have shown that S. 
Typhimurium ST313 is a common cause of 
gastroenteritis in healthy people but also has the ability 
to cause septicaemia, perhaps opportunistically, in an 
immune deficient human host.  Little sub-typing data 
on Salmonella from diarrhoeic stools in sub-Saharan 
Africa is available and it is important that we 
investigate how common S. Typhimurium ST313 is in 
the gut of the immune competent host: is ST313 an 
opportunist or a true pathogen? Although S. 
Typhimurium is now circulating in the human 
population there may yet prove to be an animal 
reservoir acting as the source for which humans were, 
until HIV infection expanded, the less favourable 
habitat, or sink [23]. If this hypothetical animal 
reservoir could be identified as real then the 
microevolution of virulence in human pathogens could 
be studied in detail.  
 
Is there an animal reservoir for S. Typhimurium 
ST313? 
Serovars of NTS are widespread and although 
commonly associated with specific animals, detailed 
investigations in Kenya have failed to identify an 
animal host for the S. Typhimurium strain causing 
human invasive disease [24,25]. For 137 S. 
Typhimurium isolates from patients matched with 
isolates from the food consumed, the animals they 
kept, and the environment around their home, no 
common types were found using standard molecular 
methods [24]. Further studies using phage typing and 
pulsed-field gel electrophoresis (PFGE) showed that 
104 isolates of S. Typhimurium from Nairobi and 
Kilifi in Kenya were from 11 different phage types 
and eight different PFGE patterns. The S. 
Typhimurium isolates from Kilifi, however, formed a 
cluster of mainly phage type DT56 which gave a 
single PFGE pattern [26]. These isolates were 
collected between 1994 and 1997, so they are possibly 
S. Typhimurium ST313. Although the phage type 
described, S. Typhimurium DT56, is believed to be 
host adapted to birds [27], the sequence type found in 
British birds (S. Typhimurium ST568) is different 
from the S. Typhimurium DT56 associated with 
humans in Kenya. These studies raise the possibility of 
birds as a source of S. Typhimurium ST313 and the 
relationship between the S. Typhimurium DT56 
isolates from birds and humans remains to be 
described but is of great interest. The importance of 
the detailed description of S. Typhimurium ST313 [20] 
should not be underestimated, but if the opportunities 
in our post genomic era are to be fully realised then 
this research must be translated into useful tools to 
reduce the burden of this dreadful disease [28].  The 
detailed description of the spread of S. Typhimurium 
ST313 is a major breakthrough and shows how new 
nucleic acid sequencing technology can be used for 
epidemiology of NTS infection but the expansion of S. 
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Typhimurium ST313 only partially explains the 
emergence of drug resistant, invasive, NTS infection. 
 
Other non-typhoidal serotypes of Salmonella 
associated with invasive human disease 
Regional variation [29] and differing invasive 
capability [30]  are associated with different serotypes 
and detailed epidemiology is now needed to establish 
the extent to which S. Typhimurium ST313 is 
replacing local strains. In South Africa, using more 
traditional molecular typing methods, research has 
shown considerable diversity in 652 isolates of 
invasive S. Typhimurium cultured from predominantly 
HIV-positive patients in 2006-2007 [31]. Unusual 
serotypes, such as Salmonella Isangi, have been 
associated with HIV infection, nosocomial (implying 
human-to-human) transmission and higher death rates 
[32] and in Ethiopia multiple-drug-resistant S. 
Concord was by far the most common Salmonella 
serotype found in the stools of 1,225 children in 2006 
[33].  
Has S. Typhimurium ST313 failed to penetrate 
these regions because HIV infection is not common; is 
it present but undetected; or is it not present because 
the epidemiology has not favoured it? The advantage 
of next generation sequencing (NGS) technology is the 
ability to provide information about any bacterial 
species – it is truly a molecular blood agar plate for 
modern day microbiologists. The association between 
S. Typhimurium ST313 and invasive NTS infection is 
clear, and the final proof of virulence may come from 
laboratory experiments in animal model systems [28], 
but the work remains incomplete until vaccines and 
new diagnostics are implemented for general use in 
regions of the world where invasive NTS infection is 
endemic [28] (Table). 
 
Conclusion 
Next generation sequencing is now inexpensive, 
by Western standards, and wealthy countries are 
poised to implement the technology in real time for 
public health investigations [34]. The power for 
clinical diagnostics is also being realised [35], which 
raises the possibility for reference laboratories of sub-
Saharan Africa to “leapfrog” technology currently in 
use in Europe.  Global monitoring is in place by the 
World Health Organisation’s Global Foodborne 
Infections Network [29] and new initiatives are being 
exploited to transform monitoring of infectious 
diseases by the implementation of global surveillance 
by NGS. This global system will link databases of 
clinical and epidemiological data with identification 
and a detailed genetic characterization of any and all 
microorganisms. But the question remains: how can 
we ensure that sub-Saharan populations also benefit 




Table. Key studies describing the emergence of Salmonella Typhimurium ST313  
Study Strains collected Conclusion Reference 
Comparison of human and animal 
NTS isolates by PFGE 
Kenya  
1998-2000 
Lack of demonstable animal 
reservior for new strain of S. 
Typhimiurium 
24 
Comparison of human and animal 
NTS isolates by PFGE 
Kenya  
2002-2004 
Anthroponotic transmission of new 
strain likely 
25 
Molecular epidemiology of NTS 
from two sites  
Kenya  
1994-1997 
Emergence of DT56 in humans in 
Kilifi but not in Nairobi  
26 
Genome sequencing of NTS 
isolates 
Several sub-Saharan 
countries 1977- 2010 
Emergence of ST313 as a possible 
human adapted strain of S. 
Typhimurium  
20 
Genome sequencing of NTS 
isolates 
Malawi 1997-2006 
Emergence of ST313 as a cause of 
invasive disease in humans 
19 
Microbiological study of 301 
invasive NTS isolates 
Zimbabwe 1994 - 1996 
Early description of invasive NTS in 
sub-Saharan Africa  
14 
Clinical study of AIDS patients Haiti 1983 First report of NTS in AIDS 9 
Molecular epidemiology of 652 
NTS isolates 
South Africa 2006-7 
Considerable diversity exists in 
human invasive NTS in South Africa 
31 
NTS: Non-typhoidal Salmonella 
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